pre-seed
Stage
1
Investors
About
PacingCure develops precision gene therapies targeting cardiac diseases caused by abnormal electrical properties of the heart by aiming directly at the disease mechanisms.
Explore PacingCure's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.